Very Advanced Maternal Age, TOG-2021
Very Advanced Maternal Age, TOG-2021
Very Advanced Maternal Age, TOG-2021
12710 2021;23:38–47
The Obstetrician & Gynaecologist
Review
http://onlinetog.org
Please cite this paper as: Howell A, Blott M. Very advanced maternal age. The Obstetrician & Gynaecologist 2021;23:38–47. https://doi.org/10.1111/tog.12710
disorders, structural abnormalities, fetal growth restriction Table 1 shows a summary of the risks for women of vAMA,
(FGR), stillbirth and preterm labour.7–10 These risks also from the current evidence, comparing conception with ART
increase with maternal age and multiple pregnancies. and spontaneous conception.
Pre-eclampsia complicates just 1.1% of natural conception
pregnancies and 12.6% of oocyte donation conceptions in
Early pregnancy complications
women of vAMA.10 Among oocyte donation pregnancies, the
risk of pre-eclampsia is the same among primiparous and Miscarriage rates increase with increasing maternal age. In
multiparous women, but as maternal age increases, the risks women of vAMA, the overall risk of miscarriage is 53%.14
increase. Guesdon et al.11 demonstrated that in women of Rates of miscarriage beyond the first trimester are also
vAMA undergoing oocyte donation with singleton increased.15 There is currently no intervention for the
pregnancies, the risk of gestational hypertension was 5.5% prevention of miscarriage in this group. The management
in women aged 45–49 years, rising to 19.2% above the age of of women of vAMA with both sporadic and recurrent
50 years. In the same study, babies born to women aged miscarriage is no different to younger women and has been
45–49 years had a 14.3% risk of FGR compared with 30.7% covered elsewhere.16
in women aged above 50 years. The risk of an ectopic pregnancy in women with vAMA is
Studies demonstrate women of vAMA who conceive by three times the overall risk of ectopic pregnancy in all
ART have a 23.3% risk of delivering a baby before 36 weeks women, with studies17 demonstrating a 6.9% risk of ectopic
of gestation compared with a 9.3% risk in vAMA women pregnancy in women aged 44 years or older. Conception by
who conceive spontaneously,9 independent of parity. Babies ART is not protective against ectopic pregnancy. It is likely
conceived by ART had a 22.1% risk of being born with a low that age-related changes associated with exposure of risk
birth weight (<2500 g), while babies conceived factors are directly related to maternal age.18
spontaneously have a 7.4% risk. Studies in this area are Management of ectopic pregnancies should follow local
often limited in information as to whether the embryo was protocols based on national guidelines.16,19 Clinicians should
autologous or donated. be aware there is some evidence that women aged 40 years
Women of vAMA who become pregnant as a consequence and older with ectopic pregnancies are twice as likely to need
of ART should, like all women, have a risk assessment at a blood transfusion than younger women.20 A VTE
booking; they should be offered low-dose aspirin (150 mg) reassessment after miscarriage or ectopic pregnancy should
from 12 weeks of gestation until delivery.12 They should also be performed, following findings from the most recent
be assessed for VTE, since women who have conceived with confidential enquiry into maternal deaths in the UK.13
ART are at increased risk, particularly in the first trimester.
The most recent review of maternal deaths in the UK
Multiple pregnancy
recommends clear pathways for women to access early
prescriptions and support for thromboprophylaxis to Women of vAMA are more likely to have a multiple
ensure compliance.13 pregnancy than younger women.2,3,21 Figure 1 shows the
rates of multiple births in women of vAMA and all women in
the UK from 1938–2018. In 2018, women of vAMA in the UK
Table 1. Summary of the risks from the current evidence for women
had a multiple pregnancy rate of 79.3/1000 compared with
of very advanced maternal age, comparing conception with assisted 15.4/1000 in all women.2
reproductive technologies (ART) and spontaneous conception Since 1993, women of vAMA have consistently recorded
the highest multiple pregnancy rate, secondary to increasing
Pregnancy Pregnancy
conceived by ART conceived availability of ART and the number of embryos transferred.
and oocyte spontaneously In January 2009, the Human Fertilisation and Embryology
Condition donation (%) (%) Authority (HFEA) recommended elective single embryo
transfer in an effort to reduce the overall national multiple
birth rate through ART to 10%. Clinics are not to exceed a
Maternal pre-eclampsia 12.6 1.1
maximum multiple birth rate;2 however, women of vAMA
Delivery before 23.3 9.3 are often the group that receives more than one embryo. Half
36 weeks of gestation of women aged 48 years and older who had a double embryo
Risk of baby being born 22.1 7.4
transfer went on to have a multiple pregnancy. This is higher
with low birth weight than reported rates in double embryo transfers in a younger
(<2500 g) population, likely associated with the use of donated ova.3
Clinicians should be aware that patients travelling abroad
for ART are more likely to undergo multiple embryo transfer.
Figure 1. Rates of multiple births in women of very advanced maternal age (vAMA) and all women, 1938–2018.2HFEA = Human Fertilisation and
Embryology Authority; IVF = in vitro fertilisation.
Women of vAMA with multiple pregnancy have increased Table 2 shows a summary of the evidence, risks and
rates of fetal and maternal complications compared with recommendations for fetal, neonatal and maternal morbidity
women of vAMA with singleton pregnancies11,22–24 and and mortality in women of VAMA with twin and
younger women with multiple pregnancies.25 singleton pregnancies.
In women of vAMA, the risks associated with a multiple
pregnancy as a result of ART are different to a singleton
Maternal complications, risks and
pregnancy conceived spontaneously or by ART. Twin
recommendations
neonates born to women of vAMA will sustain more
adverse outcomes than singletons.22–26 After ART they are Pregnancies in women of vAMA have increased risks of pre-
56–65% more likely to be born before 37 weeks of existing medical conditions, GDM, gestational hypertension,
gestation.23,25,26 Birth before 32 weeks of gestation is also pre-eclampsia, abnormal placentation, ICU admission,
significantly increased.25 Twin infants are four times more caesarean delivery, postpartum haemorrhage (PPH), blood
likely to need intubation and are 1.5–3 times more likely to transfusion and prolonged admission to hospital.3,5,21,24,28–31
be admitted to neonatal intensive care.23,26 They are less likely to smoke cigarettes.3
Maternal complications associated with ART and multiple Fitzpatrick et al.3 found that 44% of women aged 48 years
pregnancy are worse in women of vAMA.23–25 They are or older had a reported pre-existing medical condition
significantly more likely to suffer life-threatening compared with 28% of younger women. There is little
complications, such as bleeding requiring a blood evidence to suggest which pre-existing medical conditions
transfusion and maternal admission to the intensive care have the best and worst outcomes, but women over the age of
unit (ICU);25 10–42% of women develop gestational 40 years are three times more likely to die than women in
hypertension,23,25 26–32% develop pre-eclampsia,23,25 their early 20s.13 We recommend early referral to a high-risk
10–35% develop gestational diabetes mellitus (GDM),22,25 antenatal clinic or maternal medicine clinic.
and 79.0–91.8% had a caesarean section delivery.22,25 Care must be individualised. Many of the studies looking
Antenatal care should be in line with guidance published at outcomes in women of vAMA have not separated
by the National Institute for Health and Care Excellence primiparous from multiparous women, multiple from
(NICE) on multiple pregnancy,27 but individualised singleton pregnancies, pregnancies conceived spontaneously
according to obstetric factors. Fetal surveillance should be from those conceived with ART, or pregnancies in women
offered and recommended in line with the NICE twins and with or without pre-existing co-morbidities.
triplets guideline.27 We recommend early discussions
between clinician and patient about the mode of delivery, Obesity
in light of the increased risk of preterm delivery. There is Women aged 48 years or more are more likely to be
currently no effective intervention proven to decrease the risk overweight or obese than younger women.3 Pregnant
of preterm delivery. women who are obese are at greater risk of pre-eclampsia,
Hypothyroidism
GDM = Gestational diabetes mellitus; NICE = National Institute for Hypothyroidism is more common in women of vAMA.30 The
Health and Care Excellence.
relationship between pre-existing hypothyroidism and
adverse pregnancy outcomes is well established.
GDM and caesarean birth than women with a normal body Surveillance of thyroid function and treatment with
mass index (BMI). There is also a higher risk of fetal neural levothyroxine is an effective management strategy.
tube defects associated with obesity.32 The management of
women with vAMA who are overweight or obese is no Venous thromboembolism
different to that of younger overweight or obese women and Evidence that maternal age affects rates of VTE is conflicting:
has been covered elsewhere.32 In our experience, the early Fitzpatrick et al.3 found that rates of thrombotic events were
initiation of high dose folic acid (5 mg) is often missed in the same in women across all age groups; however, previous
this group. large studies have shown that women over the age of 35 years
Table 3. A summary of maternal complications, risks and recommendations in women of very advanced maternal age (vAMA)
Pre-existing medical 44% (of women aged 48 years or older) Early referral to a high-risk antenatal clinic or maternal medicine
complication clinic
Gestational diabetes mellitus 12.6–21.0% Offer screening at 16–18 weeks of gestation in addition to screening
35.1% (in twin pregnancies conceived by at 26–28 weeks of gestation
assisted reproductive technology) Women of vAMA are nine times more likely to require insulin
Hypertensive disease 6–32% Pre-pregnancy counselling should be offered to all women with pre-
existing hypertension, including a review of antihypertensive
medications, an up-to-date echocardiogram, renal function tests
and renal imaging
Advise low-dose aspirin 150 mg from 12 weeks of gestation until
delivery
Regular blood pressure monitoring in the third trimester
Previous uterine surgery 26% (of women aged 48 years or older) Early referral to a high-risk antenatal clinic
Placenta praevia Three times more likely to have placenta Fetal anomaly ultrasound scan between 18 and 21 weeks of
praevia than younger women gestation
Those involved in scanning should be aware of the increased risk of
placenta praevia in women of vAMA
PPH 25% Plans and precautions to minimise the risk of PPH should be
Women of vAMA are almost four times discussed. Investigate and treat anaemia
more likely to need blood products than Discuss the role of prophylactic uterotonics in the management of
younger women the third stage of labour
Antenatal hospital admission 30% Thrombophrophylaxis is recommended for women of vAMA with
additional risk factors
Admission alone increases venous thromboembolism risk 12-fold
Admission to intensive care unit 33.5 times more likely to be admitted than Consider offering care in a place with appropriate intensive care
younger women support for both mother and neonate(s)
High-risk women of vAMA to be seen in a high-risk anaesthetic clinic
at 30–32 weeks of gestation
On-call consultant anaesthetist should be made aware when a
woman of vAMA is admitted to the unit
often born before 37 weeks of gestation,3,921,22,28,30,44 discussed.52 There is currently no consensus on the
admitted to the neonatal intensive care unit (NICU),29,30 management of later pregnancy for these women. In
more often born small for gestational age (SGA),28,34,45–47 or addition to serial growth scans for women of vAMA, we
born with a birthweight of less than 2500 g.3,29,48 recommend asking women to monitor fetal movements
Fitzpatrick et al.3 found that women aged 48 years and until delivery and informing them to sleep in the right or
above are twice as likely to deliver spontaneously before left lateral position. An induction of labour can be offered,
37 weeks of gestation and 4.5 times more likely to deliver particularly beyond 37 weeks of gestation. Clinicians and
prematurely because of iatrogenic intervention. Women of women of vAMA must be able to discuss balancing the
vAMA are twice as likely to have a SGA baby28 and have a benefits and risks of remaining pregnant and waiting for
32% chance of having a baby with a birthweight of less than spontaneous labour against the benefits and risks of
2500 g.3 The high rate of babies born with a weight below induction of labour and elective caesarean section.
2500 g was shown to be associated with prematurity rather
than FGR.3 One in six babies born to women of vAMA need Trisomy and congenital anomalies
admission to NICU.30 Appropriate plans for care need to be The risk of Down syndrome (trisomy 21) is directly related to
made; such plans may involve a transfer of care, in liaison maternal age if a pregnancy is conceived spontaneously. In
with the neonatology team. The increased risk of neonatal donor embryos, it is related to the age of the donor. The
admission means that having premature and SGA babies can incidence of trisomy 21 at term is 1:1350 for a 25-year-old
have significant long-term and short-term economic and woman (or donor). This increases to 1:35 at the age of
psychosocial effects on the mother and family.21,29,30 45 years and 1:25 at the age of 49 years.57 The live birth rate
Studies have shown that singleton pregnancies are likely to of cases of trisomy 21 to women of vAMA is significantly
have less perinatal morbidity than multiples;35 however, there lower than 1:35, probably owing to the use of younger donor
is currently a paucity of studies looking at how maternal embryos and, possibly, the availability of legal termination of
complications and risk factors lead to iatrogenic preterm pregnancy services.
delivery, neonatal admissions, lower birthweight and In the UK, the combined test is part of a national screening
perinatal morbidity and mortality. programme. An older woman is more likely to have a screen-
positive result than a younger woman because she starts with
Perinatal mortality a higher age-specific risk of Down syndrome. The test is more
Although many studies report adverse perinatal outcomes in likely to detect a Down syndrome pregnancy in an older
women of vAMA, the absolute rate of stillbirth and perinatal woman than in a younger woman. In women of vAMA who
death is between 1.00 and 1.87%3,5,49 compared with 0.55% have conceived with their own embryos, there is a 95%
in younger women.49,50 detection rate for Down syndrome (higher than in any other
Perinatal mortality rates are 2.0–3.8 times higher in babies age group).58
born to women of vAMA3,9,49–52 and, as with women of all Using a cut-off of 1 in 150 at term as a screen-positive
ages, prematurity and SGA babies account for a significant result, one in four women of vAMA will screen positive.58
number of stillbirths and early neonatal deaths in the UK. A screen-positive result requires careful counselling.
Clinicians must be aware that primiparous women and Invasive diagnostic testing (amniocentesis or chorionic
black women are the highest risk group for stillbirth and that villous sampling) can be offered; it gives accurate results
obesity and additional medical comorbidities are additional but has a small risk of miscarriage. Non-invasive prenatal
risk factors for stillbirth.50,53 While women should be testing (NIPT) may be an alternative to invasive testing; it
encouraged to address factors such as obesity, the only way detects 99% of Down syndrome cases and has no risk of
to prevent antepartum stillbirth is to offer timed delivery in miscarriage; some women may prefer this option. A small
the form of an induction of labour or an elective caesarean risk of false-positive results means it is recommended that
section.53–55 There is some evidence that women aged any positive NIPT result is confirmed with invasive
44 years and older benefited from delivery by 38 weeks of diagnostic testing if the woman is considering termination
gestation to reduce stillbirth.56 of pregnancy on the basis of trisomy. There is currently no
We recommend that all women of vAMA are advised to national guidance on the role of NIPT in antenatal care
take low-dose aspirin from 12 weeks of gestation, have and screening.
their pregnancy associated plasma protein-A (PAPP-A) There is a significant association between congenital
measured, have serial assessment of fetal size and umbilical anomalies and trisomy; however, Fitzpatrick et al.3 found
artery Doppler from 26–28 weeks of gestation and regular similar rates of congenital anomalies between women
blood pressure monitoring in the third trimester.46 High- aged 48 years and older and younger women (1.9%
risk cases must be identified and the potential versus 1.5%). This should be reassuring to women
consequences of early delivery and prematurity of vAMA.
Screening for gestational diabetes mellitus with a glucose Regular blood pressure monitoring and urine analysis, increasing
tolerance test at 26–28 weeks if screen negative at 16–18 weeks in frequency in the third trimester of pregnancy
Venous thromboembolism risk re-assessment if
hypertensive disease develops or admission required
Women with additional risk factors (e.g. high body mass index,
Women with additional risk factors (e.g. high body mass index, multiple pregnancy, hypertensive disease, placenta praevia)
multiple pregnancy, hypertensive disease, placenta praevia) should be referred to high-risk obstetric
should be referred to high-risk obstetric anaesthetic clinic at 30–32
30 32 weeks ‘gestation
anaesthetic clinic at 30–32
30 32 weeks ‘gestation
Timing of delivery with multiple pregnancy to be guided by fetal Aim to deliver by 38 weeks’ gestation to
surveillance and maternal risk factors. No current evidence on reduce risk of stillbirth
optimum timing of delivery.
Figure 2. Suggested additional considerations in the antenatal care of women of very advanced maternal age (vAMA).
28 Haslinger C, Stoiber B, Capanna F, Schaffer M. Postponed pregnancies and 44 Waldenstr€ om U, Cnattingius S, Vixner L, Norman M. Advanced maternal
risks of very advanced maternal age. Swiss Med Wkly 2016;146:w1433. age increases the risk of very preterm birth, irrespective of parity: a
29 Ben-David A, Glasser S, Schiff E, Zahav A, Boyko V. Pregnancy and birth population-based register study. BJOG 2017;124:1235–44.
outcomes among primiparae at very advanced maternal age: at what price? 45 Arya S, Mulla Z, Plavsic S. Outcomes of women delivering at very advanced
Matern Child Health J 2016;20:833–42. maternal age. J Womens Health 2018;27:1378–84.
30 Dildy G, Jackson G, Fowers G, Oshiro B, Varner M. Very advanced 46 Royal College of Obstetricians and Gynaecologists (RCOG). Investigation and
maternal age: pregnancy after age 45. Am J Obstet Gynecol management of the small-for-gestational-age fetus. Green-top guideline
1996;175:668–74. no. 31. London: RCOG; 2014.
31 Marozio L, Picardo E, Filippini C, Mainolfi E, Berchialla P, Cavallo F, et al. 47 Odibo A, Nelson D, Stamilio D, Sehdev H, Macones G. Advanced maternal
Maternal age over 40 years and pregnancy outcome: a hospital-based age is an independent risk factor for intrauterine growth restriction. Am J
survey. J Matern Fetal Neonatal Med 2019;32:1602–8. Perinatol 2006;23:325–8.
32 Royal College of Obstetricians and Gynaecologists (RCOG). Care of women 48 Jolly M, Sebire N, Harris J, Robinson S, Regan L. The risks associated with
with obesity in pregnancy. Green-top guideline no. 72. London: RCOG; 2018. pregnancy in women aged 35 years or older. Hum Reprod
33 National Institute for Health and Care Excellence (NICE). Diabetes in 2000;15:2433–7.
pregnancy: management from preconception to the postnatal period. 49 Jacobsson B, Ladfors L, Milson I. Advanced maternal age and adverse
London: NICE; 2015. perinatal outcome. Obstet Gynecol 2004;104:727–33.
34 Carolan M. Maternal age ≥45 years and maternal and perinatal outcomes: a 50 Manktelow B, Smith L, Evans T, Hyman-Taylor P, Kurinczuk J, Field D.
review of the evidence. Midwifery 2013;29:479–89. Perinatal mortality surveillance report. UK perinatal deaths for births from
35 Schwartz A, Many A, Shapira U. Perinatal outcomes of pregnancy in the January to December 2013. Leicester: University of Leicester, The Infant
fifth decade and beyond - a comparison of very advanced maternal age Mortality and Morbidity Group. Department of Health Sciences on behalf of
groups. Sci Rep 2020;10:1809. MBBRACE; 2015.
36 Sultan AA, West J, Tata L, Fleming K, Nelson-Piercy C, Grainge M. Risk of first 51 Canterino J, Ananth C, Smulian J, Harrigan J, Vintzileos A. Maternal age and
venous thromboembolism in and around pregnancy: a population study. Br risk of fetal death in singleton gestations: USA, 1995–2000. J Matern Fetal
J Haematol 2012;156:366–73. Neonatal Med 2004;15:193–7.
37 Royal College of Obstetricians and Gynaecologists (RCOG). Reducing the risk 52 Smith GC. Prevention of stillbirth. Obstet Gynaecol 2015;17:183–7.
of venous thromboembolism during pregnancy and the puerperium. Green- 53 Reddy U, Ko C, Willinger M. Maternal age and the risk of stillbirth
top guideline no. 37a. London: RCOG; 2015. throughout pregnancy in the United States. Am J Obstet Gynecol
38 Royal College of Obstetricians and Gynaecologists (RCOG). Antepartum 2006;195:764–70.
haemorrhage. Green-top guideline no. 63. London: RCOG; 2011. 54 Wyatt P, Owolabi T, Meier C, Huang T. Age-speciflc risk of fetal loss
39 Royal College of Obstetricians and Gynaecologists (RCOG). Placenta praevia observed in a second trimester serum screening population. Am J Obstet
and placenta accreta: diagnosis and management. Green-top guideline no. Gynecol 2005;192:240–6.
27a. London: RCOG; 2018. 55 National Institute for Health and Clinical Excellence (NICE). Induction of
40 Royal College of Obstetricians and Gynaecologists (RCOG). Prevention and Labour. London: NICE; 2008.
management of postpartum haemorrhage. Green-top guideline no. 52. 56 Chaudhary S, Contag S. The effect of maternal age on fetal and neonatal
London: RCOG; 2016. mortality. J Perinatol 2017;37:800–4.
41 National Institute for Health and Care Excellence (NICE). Caesarean section. 57 Morris J, Wald N, Mutton D, Alberman E. Comparison of models of
London: NICE; 2011. maternal age-specific risk for Down syndrome live births. Prenat Diagn
42 Lisonkova S, Potts J, Muraca G, Razaz N, Sabr Y. Maternal age and severe 2003;23:252–8.
maternal morbidity: a population-based retrospective cohort study. PLoS 58 Wolfson Institute of Preventive Medicine – Barts and The London. The
Med 2017;14:e1002307. combined test [https://www.qmul.ac.uk/wolfson/services/antenatal-scree
43 Sutcliffe A, Barnes J, Belsky J, Gardiner J, Melhuish E. The health and ning/screening-tests/combined-test/].
development of children born to older mothers in the United Kingdom: 59 Cumberlege BJ. Better births. Improving outcomes of maternity services in
observational study using longitudinal cohort data. BMJ 2012;345: England: a five year forward view for maternity care. London: NHS England,
e5116. National Maternity Review; 2016.